Clin2
NCT07726069Possibly a fitNot yet recruiting

Haloperidol for nausea and vomiting from cannabis use

Cannabinoid Hyperemesis Syndrome

Treatments studied

Part of Blood & lymphatic, Eyes & vision, Genetic & congenital, Immune system & allergy, Mental health clinical trials.

This study tests whether a medicine called haloperidol can help control the severe nausea and vomiting caused by long-term cannabis use. If you are in the emergency department with these symptoms, this treatment might offer relief.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with cannabinoid hyperemesis syndrome (severe nausea and vomiting linked to long-term cannabis use).
  • You are 18 years or older.
  • You are not pregnant or breastfeeding.
  • You do not have Parkinson's disease or Lewy body dementia.
  • You are not already taking a similar medicine for another condition.
  • You have no known allergy to haloperidol.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07246187Recruiting· Phase 3
Comparing two drugs for cannabis-related nausea in the ER

This trial tests whether haloperidol or olanzapine works better to stop severe nausea and vomiting caused by heavy cannabis use. If you use cannabis nearly daily and have had episodes of vomiting that come and go, this study may help find the best treatment for you.

Toledo, Ohio
NCT06660901Recruiting
Study on cannabis use and vomiting in emergency rooms

This study looks at patients who come to the ER with belly pain or vomiting and uses cannabis, to better understand a condition called cannabinoid hyperemesis syndrome (severe nausea and vomiting caused by long-term cannabis use). If you're eligible, you'll answer a few questions to help doctors learn more.

Angers
NCT06395428Recruiting· Phase 4
Haloperidol for severe back pain in the ER

This study tests whether the medication haloperidol, given in the emergency room, can help relieve severe back pain that started on its own (not from an injury). It compares haloperidol to a common pain reliever called ketorolac.

Kalamazoo, Michigan
NCT07374939Not yet recruiting
Medical cannabis for chemotherapy nausea

This study is looking at whether medical cannabis can help with nausea caused by chemotherapy. If you are getting chemotherapy that often causes nausea, you may be able to join and use cannabis products to see if they help.

Rochester, New York
NCT07216690Recruiting· Phase 2
Pregnenolone for cannabis intoxication treatment

This trial tests whether a natural steroid called pregnenolone can help treat symptoms of cannabis intoxication. If you qualify, you would receive either pregnenolone or a placebo after using cannabis to see how you feel.

Baltimore, Maryland
NCT06859710Recruiting· Phase 1
THC and CBD as a harm reduction strategy

This study looks at whether different types of cannabis (containing THC and/or CBD) might help people who use cannabis regularly reduce potential harms. You will be asked to take cannabis in a controlled setting and complete tasks and questionnaires.

Los Angeles, California

Hear when a new Cannabinoid Hyperemesis Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.